Literature DB >> 22727974

Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions.

Daniela Pedicino1, Ada Francesca Giglio, Vincenzo Alessandro Galiffa, Pio Cialdella, Francesco Trotta, Francesca Graziani, Giovanna Liuzzo.   

Abstract

The role of inflammation and immunity in the pathogenesis and clinical manifestations of atherosclerotic disease has been widely studied. Common infectious diseases can be associated with a chronic inflammatory state which is the hallmark of atherosclerosis, thus suggesting a possible link between the two pathological conditions. Therefore, a great number of studies have tested the "infection hypothesis", but their results are conflicting. Nevertheless, several molecular and biological mechanisms possibly involved in the complex relationship between infections, immune response, vascular wall damage and atherosclerosis onset and progression have been described. The purpose of this article is to offer an overview of the principal mechanisms and molecular pathways that probably constitute the most relevant biological substrate on which the infection hypothesis is founded; some of these mechanisms are not fully understood yet. Nevertheless, their comprehension could be essential for the development of new preventive and therapeutic strategies.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727974     DOI: 10.1016/j.ijcard.2012.05.098

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

1.  Thymic emigration patterns in patients with type 2 diabetes treated with metformin.

Authors:  Grzegorz Dworacki; Olzhas Urazayev; Yerbol Bekmukhambetov; Saule Iskakova; Bartosz A Frycz; Paweł P Jagodziński; Marzena Dworacka
Journal:  Immunology       Date:  2015-10-05       Impact factor: 7.397

2.  Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease.

Authors:  H Kundi; E Kiziltunc; M Cetin; H Cicekcioglu; Z G Cetin; G Cicek; E Ornek
Journal:  Herz       Date:  2016-01-11       Impact factor: 1.443

3.  MiR-130a-5p contributed to the progression of endothelial cell injury by regulating FAS.

Authors:  Wei Wang; Wenbo Tang; Erbo Shan; Lei Zhang; Shiyuan Chen; Chaowen Yu; Yong Gao
Journal:  Eur J Histochem       Date:  2022-05-31       Impact factor: 1.966

4.  Impacts of berberine on oxidized LDL-induced proliferation of human umbilical vein endothelial cells.

Authors:  Rui-Xia Xu; Xian-Chang Sun; Chun-Yan Ma; Yu-Hong Yao; Xiao-Lin Li; Yuan-Lin Guo; Yan Zhang; Sha Li; Jian-Jun Li
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 5.  Infectious and coronary artery disease.

Authors:  Mohammad Saeid Rezaee-Zavareh; Mohammad Tohidi; Amin Sabouri; Mahdi Ramezani-Binabaj; Mohsen Sadeghi-Ghahrodi; Behzad Einollahi
Journal:  ARYA Atheroscler       Date:  2016-01

6.  Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?

Authors:  Cristina Strobescu-Ciobanu; Simona Eliza Giuşcă; Irina Draga Căruntu; Cornelia Amălinei; Andreea Rusu; Elena Cojocaru; Radu Florin Popa; Cristian Dumitru Lupaşcu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

7.  The relationship between rheumatoid factor levels and coronary artery lesion complexity and severity in patients with stable coronary artery disease.

Authors:  Elnur Alizade; Anıl Avcı; Göksel Açar; Serdar Fidan; Lütfi Öcal; Mustafa Bulut; Muhammed Tellice; Mustafa Akçakoyun; Selçuk Pala; Ali Metin Esen
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-03-06       Impact factor: 1.426

8.  Association of decreased serum sTREM-1 level with the severity of coronary artery disease: Inhibitory effect of sTREM-1 on TNF-α- and oxLDL-induced inflammatory reactions in endothelial cells.

Authors:  Daopeng Dai; Weixin Xiong; Qin Fan; Haibo Wang; Qiujing Chen; Weifeng Shen; Ruiyan Zhang; Fenghua Ding; Lin Lu; Rong Tao
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

9.  From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19.

Authors:  R Vinci; D Pedicino; F Andreotti; G Russo; A D'Aiello; R De Cristofaro; F Crea; G Liuzzo
Journal:  Int J Cardiol       Date:  2020-11-10       Impact factor: 4.164

10.  Cilostazol inhibits plasmacytoid dendritic cell activation and antigen presentation.

Authors:  Fei Sun; Zhao Yin; Hai-Sheng Yu; Quan-Xing Shi; Bei Zhao; Li-Guo Zhang; Shou-Li Wang
Journal:  J Geriatr Cardiol       Date:  2015-07       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.